Page last updated: 2024-08-23

pravastatin and Acute Lung Injury

pravastatin has been researched along with Acute Lung Injury in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cao, LP; Li, L; Nie, SN; Ren, Y; Sun, ZR; Wang, MM; Yang, ZZ; Zhang, P; Zhang, W1
Kim, JW; Kim, KH; Kim, SC; Kim, TJ; Kim, YH; Kim, YK; Kwon, SS; Lee, SH; Lee, SY; Rhee, CK; Yoon, HK1
Kang, HH; Kim, IK; Kim, JW; Kim, KH; Kim, YK; Kwon, SS; Lee, SH; Lee, SY; Rhee, CK; Yeo, CD1

Other Studies

3 other study(ies) available for pravastatin and Acute Lung Injury

ArticleYear
Pravastatin attenuates sepsis-induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of Cav-1/eNOS pathway.
    International immunopharmacology, 2021, Volume: 100

    Topics: Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Capillary Permeability; Caveolin 1; Disease Models, Animal; Endothelial Cells; Humans; Male; Mice; Nitric Oxide Synthase Type III; Pravastatin; Pulmonary Alveoli; Sepsis

2021
Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:11

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Connective Tissue Growth Factor; Cyclin D1; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Hydroxyproline; Mice; Mice, Inbred C57BL; Pravastatin; Pulmonary Fibrosis; Respiratory Distress Syndrome; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Transforming Growth Factor beta1

2010
Protective effect of pravastatin on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice.
    Experimental lung research, 2013, Volume: 39, Issue:2

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cyclophosphamide; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mice; Mice, Inbred ICR; Neutropenia; NF-kappa B; Pravastatin; Pulmonary Edema; Respiratory Distress Syndrome; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2013